Blood pressure Studies have shown that Ubiquinol, coenzyme Q10 (CoQ10), may reduce systolic blood pressure in adults. A 2025
meta-analysis of randomized controlled trials published in the International Journal of Cardiology Cardiovascular Risk and Prevention concluded that a daily dose of CoQ10 below 200 mg may be an effective adjunctive therapy for the reduction in
systolic blood pressure (SBP). A
meta-analysis published in the academic journal
Advances in Nutrition assessed CoQ10 dosing to lower systolic blood pressure in patients with
Cardiometabolic Disorders. The assessment included 1,831 individuals across 26 studies. Conclusions showed that CoQ10 supplements may be potentially effective for clinically reducing SBP in people with cardiometabolic disorders, such as
Type 2 diabetes or
Dyslipidemia. The dose recommended was 100 – 200mg per day. ==Content in foods==